Effect of n-acetylcysteine on lung injury induced by skeletal muscle ischemia reperfusion. histopathological study in rat model;Efeito de n-acetilcisteína em dano pulmonar induzido por isquemia-reperfusão de músculo esquelético. estudo histopatólogico em modelo de rato

Acta Cirurgica Brasileira

Volumn 27, Issue 2, 2012, Pages 168-171

  Sotoudeh, Amir ^a   Takhtfooladi, Mohammad Ashrafzadeh ^b   Jahanshahi, Amirali ^b   Asl, Adel Haghighi Khiabanian ^b   Takhtfooladi, Hamed Ashrafzadeh ^c   Khansari, Mohammadreza ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Acetylcysteine; Histology; Ischemia; Lung; Muscle; Rats; Reperfusion; Reperfusion Injury; Skeletal

Indexed keywords

ACETYLCYSTEINE; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMORAL ARTERY; HISTOPATHOLOGY; JUGULAR VEIN; LUNG ALVEOLUS; LUNG EDEMA; LUNG HEMORRHAGE; LUNG INJURY; LUNG PARENCHYMA; MALE; MUSCLE ISCHEMIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; REPERFUSION INJURY; SKELETAL MUSCLE;

ACETYLCYSTEINE; ANIMALS; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; LUNG; LUNG INJURY; MALE; MUSCLE, SKELETAL; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857955748     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502012000200012     Document Type: Article

References (22)

1. Beyersdorf F, Unger A, Wildhirt A. Studies of reperfusion injury in skeletal muscle: preserved cellular viability after extended periods of warm ischemia. J Cardiovasc Surg. 1991;32:664-76.
2. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002;10: 620-30.
3. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg. 1991;78:651-5.
4. Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischemia. Crit Care Med. 1993;21:1376-89.
5. Calikoglu M, Tamer L, Sucu N. The effects of caffeic acid phenethyl ester on tissue damage in lung after hindlimb ischemia-reperfusion. Pharmacol Res. 2003;48:397-403.
6. Mehmet S, Efkan UZ, Rana S. The effects of erdosteine on lung injury induced by the ischemia- reperfusion of the hind-limbs in rats. J Surg Res. 2008;145:303-7.
7. Tredger JM. N-acetylcysteine: not a simply glutathione precursor. Transplantation. 2000;69:703-4.
8. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation. 1995;92:2855-62.
9. Weinbroum AA, Rudick V, Ben-Abraham R, Kachevski E. N-acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: a possible dual protective mechanism in a dose-response study. Transplantation. 2000;69(5):853-9.
10. Eberlin KR, McCormack MC, Nguyen JT, Tatlidede HS, Randolph MA, Austen Jr W. Ischemic preconditioning of skeletal muscle mitigates remote injury and mortality. J Surg Res. 2008;148:24-30.
11. Koksel O, Yildirim C, Cinel L, Tamer L, Ozdulger A, Bastürk M, Degirmenci U, Kanik A, Cinel I. Inhibition of poly (ADPribose) polymerase attenuates lung tissue damage after hind limb ischemiareperfusion in rats. Pharmacol Res. 2005;51(5):453-62.
12. Harrison PM, Wendon YA, Gimson AES. Improvement by acetylcisteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324:1852-7.
13. Klausner JM, Paterson IS, Kobzik L. Oxygen free radical mediate ischemia-induced lung injury. Surgery. 1989;105:192-9.
14. Baggiolini M, Walz A, Kunkel SL. Neutrophil activating peptide-1/ interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045-9.
15. Galley HF, Howdle PD, Walker BE. The effect of intravenous antioxidants in patients with septic shock. Free Radic Biol Med. 1997;23:768-74.
16. Lucht WD, English DK, Bernard GR. Prevention of release of granulocyte aggregates into sheep lung lymph following endotoxemia by N-acetylcysteine. Am J Med Sci. 1987;294:161-7.
17. Schillier HJ, Reilly PM, Bulkley GB. Antioxidant therapy. Crit Care Med. 1993;21:92-102.
18. Aruoma OI, Halliwell B, Hoey BM. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593-7.
19. Borjesson A, Wang X, Sun Z, Wallen R, Deng X, Johnson E. Effects of N-acetylcysteine on pulmonary macrophage activity after intestinal ischemia and reperfusion in rats / with invited commentaries. Dig Surg. 2000;17(4):379-87.
20. Suter PM, Domenighetti G, Schaller M, Laverriere M, Ritz R, Perret C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994;105(1):190-4.
21. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, Dugo L, Calabrò G, Cucinotta G, De Sarro A, Caputi AP. Beneficial effects of n-acetylcysteine on ischemic brain injury. Br J Pharmacol. 2000;130(6):1219-26.
22. Menasché P, Grousset C, Gauduel Y, Mouas C, Piwnica A. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection. J Thorac Cardiovasc Surg. 1992;103(5):936-44.